Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oxford Immunotec Global PLC (NASDAQ:OXFD)

13.30
Delayed Data
As of Jul 29
 +0.07 / +0.53%
Today’s Change
10.01
Today|||52-Week Range
17.43
-2.35%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close13.23
Today’s open13.61
Day’s range13.19 - 13.63
Volume23,725
Average volume (3 months)60,781
Market cap$297.9M
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+43.36%
Earnings growth (this year)+3.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+27.64%
P/E ratio--
Price/Sales4.76
Price/Book3.85

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.16-1.40%
QTNTQuotient Ltd-0.18-1.10%
TROVTrovagene Inc-0.34-4.07%
LNTHLantheus Holdings In...+0.49+7.30%
Data as of 3:59pm ET, 07/29/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$49.5M
Annual profit (last year)-$22.2M
Net profit margin-44.79%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Peter James Wrighton-Smith
Chief Operations Officer
Peter Edwardson
Corporate headquarters
Abingdon, Oxfordshire

Forecasts